Old Web
English
Sign In
Acemap
>
authorDetail
>
M den Adel
M den Adel
Astellas Pharma
Immunology
Rheumatoid arthritis
Pharmacodynamics
Placebo
Osteopontin
2
Papers
30
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study
2012
Annals of the Rheumatic Diseases
Maartje J. Boumans
J G A Houbiers
Patrick Verschueren
H Ishikura
Rene Westhovens
Elisabeth Brouwer
B Rojkovich
Stephen Kelly
M den Adel
John D. Isaacs
Hilde Jacobs
J. Gomez-Reino
G M Holtkamp
A Hastings
Danielle M. Gerlag
P P Tak
Show All
Source
Cite
Save
Citations (30)
Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis in a randomized, placebo controlled, combined first-in-man and proof of concept study
2010
Arthritis & Rheumatism
Marie Boumans
Jos G A Houbiers
Patrick Verschueren
A. Ishikura
Rene Westhovens
Elisabeth Brouwer
B Rojkovich
S. Kelly
M den Adel
John D. Isaacs
J. Gomez-Reino
G M Holtkamp
Danielle M. Gerlag
P P Tak
Show All
Source
Cite
Save
Citations (0)
1